APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epirubicin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Epirubicin Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchEpirubicin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Epirubicin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Epirubicin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epirubicin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Epirubicin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Epirubicin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Epirubicin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Epirubicin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Epirubicin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Epirubicin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Epirubicin include TEVA, Xinshidai Pharma, Mylan, Pfizer, Salius, Miracalus Pharma, Areva Pharma, Anishya Pharma and Actavis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Epirubicin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Epirubicin, also provides the sales of main regions and countries. Of the upcoming market potential for Epirubicin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epirubicin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epirubicin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Epirubicin sales, projected growth trends, production technology, application and end-user industry.

Epirubicin Segment by Company

TEVA

Xinshidai Pharma

Mylan

Pfizer

Salius

Miracalus Pharma

Areva Pharma

Anishya Pharma

Actavis

Epirubicin Segment by Type

50mg/Vial

200mg/Vial

100mg/Vial

Epirubicin Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Epirubicin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epirubicin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epirubicin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epirubicin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Epirubicin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Epirubicin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epirubicin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epirubicin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg/Vial Major Manufacturers Table 3. 200mg/Vial Major Manufacturers Table 4. 100mg/Vial Major Manufacturers Table 5. Global Epirubicin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Epirubicin Industry Trends Table 10. Epirubicin Industry Drivers Table 11. Epirubicin Industry Opportunities and Challenges Table 12. Epirubicin Industry Restraints Table 13. Global Epirubicin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Epirubicin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Epirubicin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Epirubicin Revenue Market Share by Region (2021-2026) Table 17. Global Epirubicin Revenue Market Share by Region (2027-2032) Table 18. Global Epirubicin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 19. Global Epirubicin Sales by Region (2021-2026) & (kg) Table 20. Global Epirubicin Sales by Region (2027-2032) & (kg) Table 21. Global Epirubicin Sales Market Share by Region (2021-2026) Table 22. Global Epirubicin Sales Market Share by Region (2027-2032) Table 23. Global Epirubicin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Epirubicin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Epirubicin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Epirubicin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Epirubicin Sales Price (US$/kg) of Manufacturers (2021-2026) Table 28. Global Epirubicin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Epirubicin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Epirubicin Manufacturers, Product Type & Application Table 31. Global Epirubicin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Epirubicin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Epirubicin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Epirubicin Revenue Market Share by Type (2021-2026) Table 38. Global Epirubicin Revenue Market Share by Type (2027-2032) Table 39. Global Epirubicin Sales by Type 2021 VS 2025 VS 2032 (kg) Table 40. Global Epirubicin Sales by Type (2021-2026) & (kg) Table 41. Global Epirubicin Sales by Type (2027-2032) & (kg) Table 42. Global Epirubicin Sales Market Share by Type (2021-2026) Table 43. Global Epirubicin Sales Market Share by Type (2027-2032) Table 44. Global Epirubicin Price by Type (2021-2026) & (US$/kg) Table 45. Global Epirubicin Price by Type (2027-2032) & (US$/kg) Table 46. Global Epirubicin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Epirubicin Revenue Market Share by Application (2021-2026) Table 50. Global Epirubicin Revenue Market Share by Application (2027-2032) Table 51. Global Epirubicin Sales by Application 2021 VS 2025 VS 2032 (kg) Table 52. Global Epirubicin Sales by Application (2021-2026) & (kg) Table 53. Global Epirubicin Sales by Application (2027-2032) & (kg) Table 54. Global Epirubicin Sales Market Share by Application (2021-2026) Table 55. Global Epirubicin Sales Market Share by Application (2027-2032) Table 56. Global Epirubicin Price by Application (2021-2026) & (US$/kg) Table 57. Global Epirubicin Price by Application (2027-2032) & (US$/kg) Table 58. TEVA Company Information Table 59. TEVA Business Overview Table 60. TEVA Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. TEVA Epirubicin Product Portfolio Table 62. TEVA Recent Development Table 63. Xinshidai Pharma Company Information Table 64. Xinshidai Pharma Business Overview Table 65. Xinshidai Pharma Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Xinshidai Pharma Epirubicin Product Portfolio Table 67. Xinshidai Pharma Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Mylan Epirubicin Product Portfolio Table 72. Mylan Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Pfizer Epirubicin Product Portfolio Table 77. Pfizer Recent Development Table 78. Salius Company Information Table 79. Salius Business Overview Table 80. Salius Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Salius Epirubicin Product Portfolio Table 82. Salius Recent Development Table 83. Miracalus Pharma Company Information Table 84. Miracalus Pharma Business Overview Table 85. Miracalus Pharma Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Miracalus Pharma Epirubicin Product Portfolio Table 87. Miracalus Pharma Recent Development Table 88. Areva Pharma Company Information Table 89. Areva Pharma Business Overview Table 90. Areva Pharma Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Areva Pharma Epirubicin Product Portfolio Table 92. Areva Pharma Recent Development Table 93. Anishya Pharma Company Information Table 94. Anishya Pharma Business Overview Table 95. Anishya Pharma Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Anishya Pharma Epirubicin Product Portfolio Table 97. Anishya Pharma Recent Development Table 98. Actavis Company Information Table 99. Actavis Business Overview Table 100. Actavis Epirubicin Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 101. Actavis Epirubicin Product Portfolio Table 102. Actavis Recent Development Table 103. North America Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Epirubicin Sales by Type (2021-2026) & (kg) Table 106. North America Epirubicin Sales by Type (2027-2032) & (kg) Table 107. North America Epirubicin Sales Price by Type (2021-2026) & (US$/kg) Table 108. North America Epirubicin Sales Price by Type (2027-2032) & (US$/kg) Table 109. North America Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Epirubicin Sales by Application (2021-2026) & (kg) Table 112. North America Epirubicin Sales by Application (2027-2032) & (kg) Table 113. North America Epirubicin Sales Price by Application (2021-2026) & (US$/kg) Table 114. North America Epirubicin Sales Price by Application (2027-2032) & (US$/kg) Table 115. North America Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Epirubicin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Epirubicin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Epirubicin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 119. North America Epirubicin Sales by Country (2021-2026) & (kg) Table 120. North America Epirubicin Sales by Country (2027-2032) & (kg) Table 121. North America Epirubicin Sales Price by Country (2021-2026) & (US$/kg) Table 122. North America Epirubicin Sales Price by Country (2027-2032) & (US$/kg) Table 123. United States Epirubicin Revenue (2021-2032) & (US$ Million) Table 124. Canada Epirubicin Revenue (2021-2032) & (US$ Million) Table 125. Mexico Epirubicin Revenue (2021-2032) & (US$ Million) Table 126. Europe Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Epirubicin Sales by Type (2021-2026) & (kg) Table 129. Europe Epirubicin Sales by Type (2027-2032) & (kg) Table 130. Europe Epirubicin Sales Price by Type (2021-2026) & (US$/kg) Table 131. Europe Epirubicin Sales Price by Type (2027-2032) & (US$/kg) Table 132. Europe Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Epirubicin Sales by Application (2021-2026) & (kg) Table 135. Europe Epirubicin Sales by Application (2027-2032) & (kg) Table 136. Europe Epirubicin Sales Price by Application (2021-2026) & (US$/kg) Table 137. Europe Epirubicin Sales Price by Application (2027-2032) & (US$/kg) Table 138. Europe Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Epirubicin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Epirubicin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Epirubicin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 142. Europe Epirubicin Sales by Country (2021-2026) & (kg) Table 143. Europe Epirubicin Sales by Country (2027-2032) & (kg) Table 144. Europe Epirubicin Sales Price by Country (2021-2026) & (US$/kg) Table 145. Europe Epirubicin Sales Price by Country (2027-2032) & (US$/kg) Table 146. Germany Epirubicin Revenue (2021-2032) & (US$ Million) Table 147. France Epirubicin Revenue (2021-2032) & (US$ Million) Table 148. U.K. Epirubicin Revenue (2021-2032) & (US$ Million) Table 149. Italy Epirubicin Revenue (2021-2032) & (US$ Million) Table 150. Russia Epirubicin Revenue (2021-2032) & (US$ Million) Table 151. Spain Epirubicin Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Epirubicin Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Epirubicin Revenue (2021-2032) & (US$ Million) Table 154. Sweden Epirubicin Revenue (2021-2032) & (US$ Million) Table 155. Poland Epirubicin Revenue (2021-2032) & (US$ Million) Table 156. China Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 157. China Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 158. China Epirubicin Sales by Type (2021-2026) & (kg) Table 159. China Epirubicin Sales by Type (2027-2032) & (kg) Table 160. China Epirubicin Sales Price by Type (2021-2026) & (US$/kg) Table 161. China Epirubicin Sales Price by Type (2027-2032) & (US$/kg) Table 162. China Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 163. China Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 164. China Epirubicin Sales by Application (2021-2026) & (kg) Table 165. China Epirubicin Sales by Application (2027-2032) & (kg) Table 166. China Epirubicin Sales Price by Application (2021-2026) & (US$/kg) Table 167. China Epirubicin Sales Price by Application (2027-2032) & (US$/kg) Table 168. Asia Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Epirubicin Sales by Type (2021-2026) & (kg) Table 171. Asia Epirubicin Sales by Type (2027-2032) & (kg) Table 172. Asia Epirubicin Sales Price by Type (2021-2026) & (US$/kg) Table 173. Asia Epirubicin Sales Price by Type (2027-2032) & (US$/kg) Table 174. Asia Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Epirubicin Sales by Application (2021-2026) & (kg) Table 177. Asia Epirubicin Sales by Application (2027-2032) & (kg) Table 178. Asia Epirubicin Sales Price by Application (2021-2026) & (US$/kg) Table 179. Asia Epirubicin Sales Price by Application (2027-2032) & (US$/kg) Table 180. Asia Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Epirubicin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Epirubicin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Epirubicin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 184. Asia Epirubicin Sales by Country (2021-2026) & (kg) Table 185. Asia Epirubicin Sales by Country (2027-2032) & (kg) Table 186. Asia Epirubicin Sales Price by Country (2021-2026) & (US$/kg) Table 187. Asia Epirubicin Sales Price by Country (2027-2032) & (US$/kg) Table 188. Japan Epirubicin Revenue (2021-2032) & (US$ Million) Table 189. South Korea Epirubicin Revenue (2021-2032) & (US$ Million) Table 190. India Epirubicin Revenue (2021-2032) & (US$ Million) Table 191. Australia Epirubicin Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Epirubicin Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Epirubicin Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Epirubicin Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Epirubicin Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Epirubicin Sales by Type (2021-2026) & (kg) Table 197. SAMEA Epirubicin Sales by Type (2027-2032) & (kg) Table 198. SAMEA Epirubicin Sales Price by Type (2021-2026) & (US$/kg) Table 199. SAMEA Epirubicin Sales Price by Type (2027-2032) & (US$/kg) Table 200. SAMEA Epirubicin Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Epirubicin Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Epirubicin Sales by Application (2021-2026) & (kg) Table 203. SAMEA Epirubicin Sales by Application (2027-2032) & (kg) Table 204. SAMEA Epirubicin Sales Price by Application (2021-2026) & (US$/kg) Table 205. SAMEA Epirubicin Sales Price by Application (2027-2032) & (US$/kg) Table 206. SAMEA Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Epirubicin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Epirubicin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Epirubicin Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 210. SAMEA Epirubicin Sales by Country (2021-2026) & (kg) Table 211. SAMEA Epirubicin Sales by Country (2027-2032) & (kg) Table 212. SAMEA Epirubicin Sales Price by Country (2021-2026) & (US$/kg) Table 213. SAMEA Epirubicin Sales Price by Country (2027-2032) & (US$/kg) Table 214. Brazil Epirubicin Revenue (2021-2032) & (US$ Million) Table 215. Argentina Epirubicin Revenue (2021-2032) & (US$ Million) Table 216. Chile Epirubicin Revenue (2021-2032) & (US$ Million) Table 217. Colombia Epirubicin Revenue (2021-2032) & (US$ Million) Table 218. Peru Epirubicin Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Epirubicin Revenue (2021-2032) & (US$ Million) Table 220. Israel Epirubicin Revenue (2021-2032) & (US$ Million) Table 221. UAE Epirubicin Revenue (2021-2032) & (US$ Million) Table 222. Turkey Epirubicin Revenue (2021-2032) & (US$ Million) Table 223. Iran Epirubicin Revenue (2021-2032) & (US$ Million) Table 224. Egypt Epirubicin Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Epirubicin Distributors List Table 228. Epirubicin Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Epirubicin Image Figure 2. Global Epirubicin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epirubicin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg/Vial Image Figure 5. 200mg/Vial Image Figure 6. 100mg/Vial Image Figure 7. Global Epirubicin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Epirubicin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Epirubicin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Epirubicin Revenue (2021-2032) & (US$ Million) Figure 14. Global Epirubicin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Epirubicin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Epirubicin Revenue Market Share by Region (2021-2032) Figure 17. Global Epirubicin Sales (2021-2032) & (kg) Figure 18. Global Epirubicin Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 19. Global Epirubicin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Epirubicin Sales YoY (2021-2032) & (kg) Figure 21. Europe Epirubicin Sales YoY (2021-2032) & (kg) Figure 22. China Epirubicin Sales YoY (2021-2032) & (kg) Figure 23. Asia (Excluding China) Epirubicin Sales YoY (2021-2032) & (kg) Figure 24. South America, Middle East and Africa Epirubicin Sales YoY (2021-2032) & (kg) Figure 25. Global Epirubicin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Epirubicin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Epirubicin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Epirubicin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Epirubicin Revenue Market Share by Type (2021-2032) Figure 31. Global Epirubicin Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 32. Global Epirubicin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Epirubicin Sales Market Share by Type (2021-2032) Figure 34. Global Epirubicin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Epirubicin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Epirubicin Revenue Market Share by Application (2021-2032) Figure 37. Global Epirubicin Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 38. Global Epirubicin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Epirubicin Sales Market Share by Application (2021-2032) Figure 40. North America Epirubicin Revenue Share by Type (2021-2032) Figure 41. North America Epirubicin Sales Share by Type (2021-2032) Figure 42. North America Epirubicin Revenue Share by Application (2021-2032) Figure 43. North America Epirubicin Sales Share by Application (2021-2032) Figure 44. North America Epirubicin Revenue Share by Country (2021-2032) Figure 45. North America Epirubicin Sales Share by Country (2021-2032) Figure 46. Europe Epirubicin Revenue Share by Type (2021-2032) Figure 47. Europe Epirubicin Sales Share by Type (2021-2032) Figure 48. Europe Epirubicin Revenue Share by Application (2021-2032) Figure 49. Europe Epirubicin Sales Share by Application (2021-2032) Figure 50. Europe Epirubicin Revenue Share by Country (2021-2032) Figure 51. Europe Epirubicin Sales Share by Country (2021-2032) Figure 52. China Epirubicin Revenue Share by Type (2021-2032) Figure 53. China Epirubicin Sales Share by Type (2021-2032) Figure 54. China Epirubicin Revenue Share by Application (2021-2032) Figure 55. China Epirubicin Sales Share by Application (2021-2032) Figure 56. Asia Epirubicin Revenue Share by Type (2021-2032) Figure 57. Asia Epirubicin Sales Share by Type (2021-2032) Figure 58. Asia Epirubicin Revenue Share by Application (2021-2032) Figure 59. Asia Epirubicin Sales Share by Application (2021-2032) Figure 60. Asia Epirubicin Revenue Share by Country (2021-2032) Figure 61. Asia Epirubicin Sales Share by Country (2021-2032) Figure 62. SAMEA Epirubicin Revenue Share by Type (2021-2032) Figure 63. SAMEA Epirubicin Sales Share by Type (2021-2032) Figure 64. SAMEA Epirubicin Revenue Share by Application (2021-2032) Figure 65. SAMEA Epirubicin Sales Share by Application (2021-2032) Figure 66. SAMEA Epirubicin Revenue Share by Country (2021-2032) Figure 67. SAMEA Epirubicin Sales Share by Country (2021-2032) Figure 68. Epirubicin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Epirubicin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/Vial
  • 200mg/Vial
  • 100mg/Vial
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • TEVA
  • Xinshidai Pharma
  • Mylan
  • Pfizer
  • Salius
  • Miracalus Pharma
  • Areva Pharma
  • Anishya Pharma
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Epirubicin Market by Type
  3. 1.2.1 Global Epirubicin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg/Vial
  5. 1.2.3 200mg/Vial
  6. 1.2.4 100mg/Vial
  7. 1.3 Epirubicin Market by Application
  8. 1.3.1 Global Epirubicin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Epirubicin Market Dynamics
  1. 2.1 Epirubicin Industry Trends
  2. 2.2 Epirubicin Industry Drivers
  3. 2.3 Epirubicin Industry Opportunities and Challenges
  4. 2.4 Epirubicin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Epirubicin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Epirubicin Revenue by Region
  3. 3.2.1 Global Epirubicin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Epirubicin Revenue by Region (2021-2026)
  5. 3.2.3 Global Epirubicin Revenue by Region (2027-2032)
  6. 3.2.4 Global Epirubicin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Epirubicin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Epirubicin Sales by Region
  9. 3.4.1 Global Epirubicin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Epirubicin Sales by Region (2021-2026)
  11. 3.4.3 Global Epirubicin Sales by Region (2027-2032)
  12. 3.4.4 Global Epirubicin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Epirubicin Revenue by Manufacturers
  2. 4.1.1 Global Epirubicin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Epirubicin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Epirubicin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Epirubicin Sales by Manufacturers
  6. 4.2.1 Global Epirubicin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Epirubicin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Epirubicin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Epirubicin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Epirubicin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Epirubicin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Epirubicin Manufacturers, Product Type & Application
  13. 4.7 Global Epirubicin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Epirubicin Market CR5 and HHI
  16. 4.8.2 2025 Epirubicin Tier 1, Tier 2, and Tier 3
5 Epirubicin Market by Type
  1. 5.1 Global Epirubicin Revenue by Type
  2. 5.1.1 Global Epirubicin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Epirubicin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Epirubicin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Epirubicin Sales by Type
  6. 5.2.1 Global Epirubicin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Epirubicin Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Epirubicin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Epirubicin Price by Type
6 Epirubicin Market by Application
  1. 6.1 Global Epirubicin Revenue by Application
  2. 6.1.1 Global Epirubicin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Epirubicin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Epirubicin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Epirubicin Sales by Application
  6. 6.2.1 Global Epirubicin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Epirubicin Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Epirubicin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Epirubicin Price by Application
7 Company Profiles
  1. 7.1 TEVA
  2. 7.1.1 TEVA Company Information
  3. 7.1.2 TEVA Business Overview
  4. 7.1.3 TEVA Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 TEVA Epirubicin Product Portfolio
  6. 7.1.5 TEVA Recent Developments
  7. 7.2 Xinshidai Pharma
  8. 7.2.1 Xinshidai Pharma Company Information
  9. 7.2.2 Xinshidai Pharma Business Overview
  10. 7.2.3 Xinshidai Pharma Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Xinshidai Pharma Epirubicin Product Portfolio
  12. 7.2.5 Xinshidai Pharma Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Epirubicin Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Epirubicin Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Salius
  26. 7.5.1 Salius Company Information
  27. 7.5.2 Salius Business Overview
  28. 7.5.3 Salius Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Salius Epirubicin Product Portfolio
  30. 7.5.5 Salius Recent Developments
  31. 7.6 Miracalus Pharma
  32. 7.6.1 Miracalus Pharma Company Information
  33. 7.6.2 Miracalus Pharma Business Overview
  34. 7.6.3 Miracalus Pharma Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Miracalus Pharma Epirubicin Product Portfolio
  36. 7.6.5 Miracalus Pharma Recent Developments
  37. 7.7 Areva Pharma
  38. 7.7.1 Areva Pharma Company Information
  39. 7.7.2 Areva Pharma Business Overview
  40. 7.7.3 Areva Pharma Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Areva Pharma Epirubicin Product Portfolio
  42. 7.7.5 Areva Pharma Recent Developments
  43. 7.8 Anishya Pharma
  44. 7.8.1 Anishya Pharma Company Information
  45. 7.8.2 Anishya Pharma Business Overview
  46. 7.8.3 Anishya Pharma Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Anishya Pharma Epirubicin Product Portfolio
  48. 7.8.5 Anishya Pharma Recent Developments
  49. 7.9 Actavis
  50. 7.9.1 Actavis Company Information
  51. 7.9.2 Actavis Business Overview
  52. 7.9.3 Actavis Epirubicin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Actavis Epirubicin Product Portfolio
  54. 7.9.5 Actavis Recent Developments
8 North America
  1. 8.1 North America Epirubicin Market Size by Type
  2. 8.1.1 North America Epirubicin Revenue by Type (2021-2032)
  3. 8.1.2 North America Epirubicin Sales by Type (2021-2032)
  4. 8.1.3 North America Epirubicin Price by Type (2021-2032)
  5. 8.2 North America Epirubicin Market Size by Application
  6. 8.2.1 North America Epirubicin Revenue by Application (2021-2032)
  7. 8.2.2 North America Epirubicin Sales by Application (2021-2032)
  8. 8.2.3 North America Epirubicin Price by Application (2021-2032)
  9. 8.3 North America Epirubicin Market Size by Country
  10. 8.3.1 North America Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Epirubicin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Epirubicin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Epirubicin Market Size by Type
  2. 9.1.1 Europe Epirubicin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Epirubicin Sales by Type (2021-2032)
  4. 9.1.3 Europe Epirubicin Price by Type (2021-2032)
  5. 9.2 Europe Epirubicin Market Size by Application
  6. 9.2.1 Europe Epirubicin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Epirubicin Sales by Application (2021-2032)
  8. 9.2.3 Europe Epirubicin Price by Application (2021-2032)
  9. 9.3 Europe Epirubicin Market Size by Country
  10. 9.3.1 Europe Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Epirubicin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Epirubicin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Epirubicin Market Size by Type
  2. 10.1.1 China Epirubicin Revenue by Type (2021-2032)
  3. 10.1.2 China Epirubicin Sales by Type (2021-2032)
  4. 10.1.3 China Epirubicin Price by Type (2021-2032)
  5. 10.2 China Epirubicin Market Size by Application
  6. 10.2.1 China Epirubicin Revenue by Application (2021-2032)
  7. 10.2.2 China Epirubicin Sales by Application (2021-2032)
  8. 10.2.3 China Epirubicin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Epirubicin Market Size by Type
  2. 11.1.1 Asia Epirubicin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Epirubicin Sales by Type (2021-2032)
  4. 11.1.3 Asia Epirubicin Price by Type (2021-2032)
  5. 11.2 Asia Epirubicin Market Size by Application
  6. 11.2.1 Asia Epirubicin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Epirubicin Sales by Application (2021-2032)
  8. 11.2.3 Asia Epirubicin Price by Application (2021-2032)
  9. 11.3 Asia Epirubicin Market Size by Country
  10. 11.3.1 Asia Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Epirubicin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Epirubicin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Epirubicin Market Size by Type
  2. 12.1.1 SAMEA Epirubicin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Epirubicin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Epirubicin Price by Type (2021-2032)
  5. 12.2 SAMEA Epirubicin Market Size by Application
  6. 12.2.1 SAMEA Epirubicin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Epirubicin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Epirubicin Price by Application (2021-2032)
  9. 12.3 SAMEA Epirubicin Market Size by Country
  10. 12.3.1 SAMEA Epirubicin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Epirubicin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Epirubicin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Epirubicin Value Chain Analysis
  2. 13.1.1 Epirubicin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Epirubicin Production Mode & Process
  6. 13.2 Epirubicin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Epirubicin Distributors
  9. 13.2.3 Epirubicin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst